The Bilakhia Group established our global Med-Tech company, Meril to foster innovation, design, and development of novel, clinically relevant, and state-of-the-art medical devices. Healthcare is essential to the future growth of India. We are faced with unique challenges by being one of the largest populations in the world. Were some see disadvantages to this close quartered population, we see opportunities to mitigate human suffering by improving the quality of everyday life.

Our journey has only solidified our goal of maintaining an uncompromising commitment to solid R&D and innovation in manufacturing medical device technology. Meril has expanded beyond the initial development of revolutionary medical tools to include training and education of care providers, best scientific communication, and the latest distribution avenues.

Meril proudly manufactures new technology in:

Vascular Intervention
Devices

  • Cardio,perpheral & Nuuro -Stents & Catheters
  • Structural heart Disrase - TAVI & other Herat valves
  • Congenstive heart failure
  • Cardio,perpheral & Nuuro -Stents & Catheters Structural heart Disrase - TAVI & other Herat valves Congenstive heart failure

Orthopedic
Implants

  • Total knee replacement
  • Total Hip Replacement
  • Trauma & spine

Diagnostic
Medical Devices

  • Sutures
  • Staplers
  • Hemostats
  • Sutgical kits
  • intra Uterine Devices (IUDs) for birth control

Endosurgical
Medical Devices

    Anayzers & Reagents

  • Biochemistry
  • Hematology
  • Immunology
  • point of care tests
  • Rapid testing

Meril lifesciecne Introduction

Our continued focus on powerful R&D is reflected by the diverse offerings and exceptional patents approved by global regulatory bodies created by Meril. In addition, Meril ensures its adherence to the best quality standards in manufacturing, scientific communication, and distribution by delivering pioneering healthcare products worldwide.

Through Meril, we have developed strong relationships with top physicians and global innovators to identify opportunities in clinical needs while creating revolutionary therapies. We have always encouraged research and academic collaboration and remain poised to embrace new exciting development opportunities. Only through our ability to communicate new ideas can we solve the most significant challenges of our world.